Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -91.53%2.96M | -87.74%2.82M | -65.91%2.46M | 34.58%62.02M | -1.13%17.12M | 198.07%34.93M | 169.73%22.96M | -15.34%7.22M | 28.75%46.09M | 55.70%17.32M |
| Cost of revenue | -91.27%3.04M | -85.93%3.22M | -51.91%3.42M | 43.16%65.8M | 8.52%18.23M | 209.35%34.78M | 187.40%22.89M | -31.00%7.11M | 10.01%45.96M | 27.61%16.79M |
| Gross profit | -149.35%-76K | -697.06%-406K | -970.91%-958K | -3,144.74%-3.78M | -309.32%-1.1M | -67.71%154K | -87.57%68K | 106.19%110K | 102.07%124.06K | 125.82%526K |
| Operating expense | -20.53%3.3M | -54.78%2.41M | -76.25%2.12M | 4.66%41.65M | 145.84%21.94M | -8.14%4.16M | 233.86%5.33M | 90.13%8.9M | 27.68%39.8M | -46.74%8.92M |
| Selling and administrative expenses | -52.71%3.77M | -59.51%2.58M | -76.25%2.12M | -4.16%42.06M | 173.05%29.66M | 43.06%7.98M | 7.64%6.37M | 61.80%8.9M | 37.76%43.89M | -35.30%10.86M |
| -General and administrative expense | -52.71%3.77M | -59.51%2.58M | -76.25%2.12M | -4.16%42.06M | 173.05%29.66M | 43.06%7.98M | 7.64%6.37M | 61.80%8.9M | 37.76%43.89M | -35.30%10.86M |
| Total other operating income | -87.70%470K | -83.57%172K | 36.36%735K | -90.00%409.17K | 298.40%7.72M | 262.96%3.82M | -75.79%1.05M | -34.27%539K | 495.58%4.09M | 6,165.77%1.94M |
| Operating profit | 15.57%-3.38M | 46.47%-2.81M | 65.06%-3.07M | -14.51%-45.43M | -174.35%-23.04M | 1.11%-4M | -401.62%-5.26M | -36.15%-8.79M | -6.79%-39.67M | 55.31%-8.4M |
| Net non-operating interest income (expenses) | 61.29%-48K | 73.33%-52K | 17.89%-101K | 67.82%-138.14K | 28.07%-82K | 37.69%-124K | -7.73%-195K | 35.94%-123K | -76.77%-429.21K | -327.09%-114K |
| Non-operating interest income | ---- | ---- | ---- | -9.70%232.8K | ---- | ---- | ---- | ---- | -51.07%257.8K | ---- |
| Non-operating interest expense | -61.29%48K | -73.33%52K | -17.89%101K | -46.01%370.93K | -28.07%82K | -37.69%124K | 7.73%195K | -35.94%123K | -10.74%687K | -76.08%114K |
| Net investment income | -96.37%8.54K | 28,428.03%235.07K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 561.3K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 33.18%-1.46M | -174.44%-6.53M | -398.65%-3.32M | -103.16%-12.37M | 90.98%-752K | -242.82%-2.19M | -1.02%-2.38M | 110.44%1.11M | 46.90%-6.09M | 27.29%-8.33M |
| Less:Other special charges | ---- | ---- | ---- | 23.69%-149.96K | ---- | ---- | ---- | ---- | -119,722.56%-196.51K | ---- |
| Less:Write off | -33.18%1.46M | 174.44%6.53M | 398.65%3.32M | 99.20%12.52M | -90.98%752K | 242.82%2.19M | 1.02%2.38M | -110.44%-1.11M | -45.18%6.28M | -27.29%8.33M |
| Other non-operating income (expenses) | 36.36%735K | -56.41%50.23K | 539K | 317.49%115.23K | ||||||
| Income before tax | 22.57%-4.89M | -19.97%-9.4M | 20.67%-5.76M | -27.82%-57.88M | -41.72%-23.87M | -132.69%-6.31M | -118.50%-7.83M | 58.03%-7.27M | 7.27%-45.28M | 44.17%-16.85M |
| Income tax | 0 | 0 | -150K | 2.14%-1.6M | 27K | 1K | -98.67%2K | 0 | -4,431.36%-1.63M | 0 |
| Net income | 23.24%-4.87M | -19.93%-9.4M | 22.97%-5.6M | -15.67%-50.49M | -42.51%-23.95M | -130.00%-6.35M | -109.88%-7.84M | 58.00%-7.27M | 10.53%-43.65M | 43.58%-16.81M |
| Net income continuous operations | 23.24%-4.87M | -19.93%-9.4M | 22.97%-5.6M | -29.06%-56.34M | -42.61%-23.97M | -130.00%-6.35M | -109.88%-7.84M | 58.00%-7.27M | 10.53%-43.65M | 43.58%-16.81M |
| Net income discontinuous operations | ---- | ---- | ---- | --5.84M | --17K | ---- | ---- | ---- | --0 | --0 |
| Noncontrolling interests | 92.94%-53K | 87.70%-53K | 81.27%-53K | -17.37%-1.94M | 22.78%-1.19M | -32.69%-751K | -18.73%-431K | -39.41%-283K | -71.70%-1.65M | -215.05%-1.54M |
| Net income attributable to the company | 13.88%-4.82M | -26.19%-9.35M | 20.61%-5.55M | -15.60%-48.55M | -49.10%-22.76M | -155.10%-5.6M | -119.70%-7.41M | 59.16%-6.99M | 12.19%-42M | 47.90%-15.26M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 13.88%-4.82M | -26.19%-9.35M | 20.61%-5.55M | -15.60%-48.55M | -49.10%-22.76M | -155.10%-5.6M | -119.70%-7.41M | 59.16%-6.99M | 12.19%-42M | 47.90%-15.26M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 13.82%-0.0034 | -26.00%-0.0066 | 20.72%-0.0039 | -15.66%-0.0384 | -49.12%-0.0162 | -155.13%-0.004 | -97.38%-0.0053 | 63.38%-0.005 | 12.63%-0.0332 | 52.68%-0.0109 |
| Diluted earnings per share | 13.82%-0.0034 | -26.00%-0.0066 | 20.72%-0.0039 | -15.66%-0.0384 | -49.12%-0.0162 | -155.13%-0.004 | -97.38%-0.0053 | 63.38%-0.005 | 12.63%-0.0332 | 52.68%-0.0109 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.